"This new capacity has been achieved by increasing production levels of Relenza Diskhaler from 60 million treatment courses to 90 million and building new capacity to produce 100 million treatment courses a year of Relenza Rotacaps. This alternative Relenza treatment was granted temporary approval by Swedish regulators earlier this month..."
It's there in black and white. They are producing 100 million Rotacaps p/a and HAVE THE APPROVAL TO SELL THEM! Why people keep dismissing this little fact is beyond me. Do you expect to be told each time a Rotacap is sold?
- Forums
- ASX - By Stock
- BTA
- refresh your memory from gsk website
refresh your memory from gsk website, page-6
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity